ArticleFrontiers in public health2025
Global and regional burdens of opioid use disorder from 1990 to 2021, with future forecasts to 2050: a systematic analysis for the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study comprehensively investigated the magnitude and temporal trends of the global burden of opioid use disorder (OUD) from 1990 to 2021 and predicted the disease burden in the next 29 years. Methods: The data originated from the Global Burden of Disease 2021 study. Incidence, prevalence, deaths, and disability-adjusted life years (DALYs) were analyzed by age-standardized rates. The estimated annual percentage change was calculated. The decomposition analysis was used to analyze the changes in burden globally and across the five social demographic index (SDI) regions from 1990 to 2021, with the affected population broken down into three key determinants at the group level: population aging, population growth, and epidemiological changes. Age-period-cohort analysis was used to estimate age, period, and cohort effects. Bayesian age-period-cohort modeling was used to predict the burden of OUD from 2021 to 2050. Results: In 2021, the global age-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR), age-standardized deaths rate (ASDR), and age-standardized DALYs rate of OUD were 198.489 [95% Uncertainty Interval (95%UI): 173.423-227.218], 24.544 (95%UI: 20.739-29.476), 1.194 (95%UI: 1.115-1.294), and 137.146 (95%UI: 112.293 -161.385) per 100,000 people, respectively. Among the 21 GBD regions, in 2021, High-income North America had the highest ASPR, ASIR, ASDR, and age-standardized DALYs rate of OUD. Overall, the global burden of OUD among males was significantly higher than that among females, especially in terms of deaths and DALYs. In terms of prevalent cases, globally, aging contributed 1.29%, population growth contributed 61.74%, and epidemiological changes contributed 36.97% to the increase in the burden of OUD. The global prevalence rate increased with age among people aged 20-30, decreased with age among those aged 30-80, and increased with age among people over 80. For males, the predicted ASPR, ASIR, ASDR, and age-standardized DALYs rate for OUD in 2050 are 239.62, 31.98, 2.42, and 206.44 per 100,000 people, respectively. Discussion: This study highlighted the substantial burden of OUD, particularly in High-income North America, young populations, and male populations. Population growth and epidemiological changes contributed significantly to the increase in the burden of OUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.